Targeting NA to protect against lethal avian flu infection

Asian lineage avian influenza virus (H7N9) is a subtype of influenza virus that can infect humans following exposure to live, infected poultry. There have been several outbreaks since the first reported case in China in 2013, and the mortality rate is as high as 39 percent. Although person-to-person transmission of the virus is unlikely, influenza viruses are constantly evolving into new strains. Therefore, there is a constant threat of emergence of more pathogenic and resistant viruses with the ability to trigger a worldwide pandemic outbreak.

Genetically engineered mosquitoes resist spreading any form of dengue

Recover from dengue once, and you’re not necessarily free and clear. The mosquito-borne disease marked by fever, rash, and debilitating pain results from any of four genetically distinct versions of the dengue virus. Previously infected people who get hit with a second of these “serotypes” can face more severe, even life-threatening symptoms. Now, by endowing a line of mosquitoes with an antibody against the virus, researchers have for the first time made insects that—at least in lab tests—appear unable to spread any form of the disease.

Highly Cited Researchers 2019

According to a Web of Science analysis, Dr. Ivelin Georgiev is one of 2019's most cited researchers in the world!  This distinction recognizes researchers with multiple top 1% cited papers in their field.   Read more at bit.ly/33cN1zJ.    

Norma Suazo, M.D.

Norma
Suazo
M.D.
Program Manager
norma.l.suazo.galeano@vumc.org

Norma Suazo Galeano has been living in Nashville since March 2017. She moved to Tennessee to Join the VCC as a Research Specialist II. She is a foreign graduate medical doctor from the country of Honduras, where she worked as Primary care physician in the country serving underserved populations around the country, and worked as a liaison between the nonprofit organization, medical doctors, volunteers and the government leaders of the country. Her field of practice includes public health, Child and maternal care as well as general surgery. Norma, also had a position at Georgia Southern University as a research assistant for project Salud es Vida. 

Norma is married and has three children who keep her busy but in her spare time she enjoys traveling, volunteering and exploring Nashville’s great outdoors. 

SuazoNorma

Naveen Suryadevara, Ph.D.

Naveen
Suryadevara
Ph.D.
Associate Basic Scientist
naveenchandra.suryadevara@vumc.org

Dr. Suryadevara received his M.Sc. in Biochemistry from Andhra University in 2007, and doctorate in Biotechnology in 2015 from Jawaharlal Nehru Technological University Hyderabad, India. His dissertation was focused on identifying susceptible SNP’s in Toll like receptors (TLR’s) and correlation of cytokines in Mycobacterium Lepra infection which resulted in 5 primary research publications. After graduation he worked as a Sr. Technical officer at Center for DNA Fingerprinting and Diagnostics (CDFD, Hyderabad, India). In 2015 Dr. Suryadevara joined Dr. Joyce’s laboratory at Vanderbilt University Medical Center as a postdoctoral trainee. His research was focused on lung-resident memory CD8+ T cells, developed recombinant proteins to install antigen specific CD8+ T cell memory in lungs and mechanisms of MHC class II antigen presentation. During this tenure he contributed to a review and a publication. He was awarded AAI Trainee Abstract Award in 2019 and best Poster Award, North American Comparative Immunology Workshop in 2017. Dr. Suryadevara is now occupying senior staff scientist position in the laboratory of Dr. James E. Crowe, Jr. and is involved in developing methods pertaining to rapid identification of therapeutic antibodies against viral infections (DARPA’s Pandemic Protection Platform program).

SuryadevaraNaveenPhD

Ginger DeBellis

Ginger
DeBellis
Sr. Project Manager
ginger.e.debellis@vumc.org

Ginger DeBellis is a Sr. Project Manager for the Vanderbilt Vaccine Center. She received her B.S. in Biology from Hawaii Pacific University. Ginger spent several years working on Next Generation Sequencing research projects at the Genomic Core Facility at Pennsylvania State University.

DeBellisGinger

Ginger DeBellis

Ginger
DeBellis
Lead Project Manager
ginger.e.debellis@vumc.org

Ginger DeBellis is a Project Manager for the Vanderbilt Vaccine Center. She received her B.S. in Biology from Hawaii Pacific University. Ginger spent several years working on Next Generation Sequencing research projects at the Genomic Core Facility at Pennsylvania State University.

Luke Myers

Luke
Michael
Myers
Application Developer
michael.l.myers@vumc.org

Luke Myers is a data analyst in the VVC. Luke has a Bachelor’s in Philosophy from the University of Oregon and transitioned into IT work with a focus on databases and Linux systems soon after graduating in 2010. When he is not thinking about data integrity and analytics, his interests include the science behind photography and how we make meaning.

MyersLukeMichael

Towards a universal flu vaccine

Flu shots can be hard to sell to the public. Even a run-of-the-mill influenza infection can be debilitating to otherwise healthy people, and lethal to those who are elderly or frail, so vaccinations are important. The problem is that flu vaccines deliver inconsistent performance. “In a good season, we’re up to 60% effectiveness, but in bad, mismatched years it can be as low as 10% or 20%,” says Barney Graham, deputy director of the Vaccine Research Center at the US National Institute of Allergy and Infectious Diseases (NIAID) in Bethesda, Maryland.